Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [916]

Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma –...

Prof Josep Llovet, Dr Richard Finn

Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma – Brought to you by Oncology Knowledge into Practice ( Prof Josep Llovet, Dr Richard Finn )

Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma

Dr Stefanie Fischer - The Christie NHS Foundation Trust, Manchester, UK

Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma ( Dr Stefanie Fischer - The Christie NHS Foundation Trust, Manchester, UK )

KEYNOTE-427 cohort B: First-line pembrolizumab monotherapy for advanced non...

Prof David McDermott - Beth Israel Deaconess Medical Center, Boston, USA

KEYNOTE-427 cohort B: First-line pembrolizumab monotherapy for advanced non-clear cell renal cell carcinoma ( Prof David McDermott - Beth Israel Deaconess Medical Center, Boston, USA )

Latest from CheckMate 650: Nivolumab plus ipilimumab for the treatment of...

Dr Sumit Subudhi - MD Anderson Cancer Center, Houston, USA

Latest from CheckMate 650: Nivolumab plus ipilimumab for the treatment of metastatic castration-resistant prostate cancer ( Dr Sumit Subudhi - MD Anderson Cancer Center, Houston, USA )

CB-839 in combination with cabozantinib in patients with clear cell and...

Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA

CB-839 in combination with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer ( Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA )

ASCO GU 2019: Updates on treatment and management of bladder cancer

Professor Matthew Galsky, Professor Ananya Choudhury, Professor Joaquim...

ASCO GU 2019: Updates on treatment and management of bladder cancer ( Professor Matthew Galsky, Professor Ananya Choudhury, Professor Joaquim Bellmunt, Dr Andrea Necchi )

ASCO GU 2019 renal highlights

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

ASCO GU 2019 renal highlights ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

BGICC 2019 ( )

Combined ibrutinib and venetoclax in patients with treatment-naïve high-risk CLL

Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA

Combined ibrutinib and venetoclax in patients with treatment-naïve high-risk CLL ( Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA )

Phase II trial of nivolumab combined with ibrutinib for patients with Richter...

Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA

Phase II trial of nivolumab combined with ibrutinib for patients with Richter transformation ( Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA )

Blinatumomab as second salvage therapy in adults with relapsed/refractory...

Prof Alessandro Rambaldi - University of Milan, Milan, Italy

$Blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-NHL ( Prof Alessandro Rambaldi - University of Milan, Milan, Italy )$

Cytotoxic T lymphocyte cell therapy for post-transplant lymphoproliferative...

Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France

Cytotoxic T lymphocyte cell therapy for post-transplant lymphoproliferative disorder in the central nervous system ( Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France )

More from ecancer